EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Periostin in Osteoporosis and Cardiovascular Disease

Marie-Eva Pickering iD, Charlotte Oris, Roland Chapurlat

Journal of the Endocrine Society · 05.06.2023 · 7 (7)

DOI: 10.1210/jendso/bvad081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Endocrine Society, online erschienen am 16.06.2023. Verfasst von Marie-Eva Pickering und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Osteoporosis (OP) and cardiovascular disease (CVD), prevalent disorders worldwide, often coexist and share common risk factors. The identification of common biomarkers could significantly improve patients’ preventive care.

Objectives

The objectives are 1, to review periostin (Postn) involvement in osteoporosis and in CVD, and 2, identify if Postn could be a common biomarker.

Design

This is a scoping review on Postn in OP and CVD.

Methods

Databases were searched, in vitro and in vivo, for publications in English on Postn, bone, and the cardiovascular system, with no limit regarding publication date.

Results

Postn appears as a key factor in OP and CVD. Its role as a potential biomarker in both pathologies is described in recent studies, but a number of limitations have been identified.

Conclusions

Current evidence provides fragmented views on Postn in OP and CVD and does not encapsulate Postn as a common pivotal thread linking these comorbidities. A number of gaps impede highlighting Postn as a common biomarker. There is room for future basic and clinical research with Postn as a marker and a target to provide new therapeutic options for aging patients with concomitant OP and CVD.

Schlagwörter

Stichwörter der Autor:innen

bonecardiovascularperiostin

Autor:innen und Institutionen

  • Rheumatology Department, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
  • Service de Biologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
  • Service de Rhumatologie, Hospices Civils de Lyon, 69437 Lyon, Cedex 03, France.
  • Inserm UMR 1033, 69437 Lyon, Cedex 03, France.

ORCID-Profile: Marie-Eva Pickering

Zitieren

APA

Pickering, M. E., Oris, C., & Chapurlat, R. (2023). Periostin in Osteoporosis and Cardiovascular Disease. Journal of the Endocrine Society, 7(7). https://doi.org/10.1210/jendso/bvad081

Vancouver

Pickering ME, Oris C, Chapurlat R. Periostin in Osteoporosis and Cardiovascular Disease. Journal of the Endocrine Society. 2023;7(7). doi:10.1210/jendso/bvad081

BibTeX
@article{Pickering2023,
  author = {Pickering, Marie-Eva and Oris, Charlotte and Chapurlat, Roland},
  title = {Periostin in Osteoporosis and Cardiovascular Disease},
  journal = {Journal of the Endocrine Society},
  year = {2023},
  volume = {7},
  number = {7},
  doi = {10.1210/jendso/bvad081}
}
Kostenlos starten →